Ketoconazole Clobetasol Propionate, Tablets Kangyan, Anxin Tablets on FDA Philippines List of Unregistered Drug Products

FA2015-095-products-compressed
The Philippines Food And Drug Administration (FDA) issued a warning about the use of unregistered drug products such as Ketoconazole Clobetasol Propionate, Tablets Kangyan, Anxin Tablets.

Public Health Warning Against the Use of the Following Unregistered Drug Products:

1. Tablets Kangyan

2. Anxin Tablets

3. Ketoconazole Clobetasol Propionate (She Wang Brand) 10 mg/ 0.5 mg per gram Ointment 7 g

The Food and Drug Administration advises the public against the use of the following unregistered drug products:

The abovementioned drug products pose potential danger or injury to the consuming public and the importation, selling or offering for sale of such is in direct violation of Republic Act No. 9711 or the Food and Drug Administration Act of 2009.

In the interest of protecting public health and safety, and pursuant to Section 12 of R.A. No. 9711, the Officers of the Field Regulatory Operations Office (FROO) are hereby ordered to seize the aforementioned unregistered drug products found in the market.

All establishments and outlets are hereby warned against selling and/or dispensing the above identified products. Anyone found selling the said products will be penalized.

Likewise, all local government units and law enforcement agencies are requested to ensure that these products are not sold or offered for sale in their localities or area of jurisdiction

All consumers are advised to purchase their medications only from FDA-licensed establishments. Please note that, in addition to inspection of establishments, product evaluation, registration and testing are measures that the government undertakes to ensure the quality, safety and efficacy of health products. Please be reminded that drug products registered with FDA Philippines bear in their labels information in English and/or in Filipino for all consumers to understand.

For more information and inquiries, please email us at info@fda.gov.ph. To Report continuous sale or distribution of unregistered health products, kindly email us via report@fda.gov.ph or you may call the telephone number (02) 807-8275. For any suspected adverse drug reaction (ADR), report immediately to FDA through this link: www.fda.gov.ph/adr-report-new and fill out all the required fields.

Other search terms: LS BL Cream Review, Wonder Cream BL Cream Review